Mail

Mail The Next New Thing Excellent idea to try to promote interactive behavior among life scientists.1 There is far too little interaction between scientists who are, understandably, frightened of divulging their work. There should be nothing wrong with talking about technical issues, though; that’s why so many forums have sprung up. I won’t be tempted by a t-shirt, though, which runs the risk of making your idea look a bit gimmick

Written byThe Scientist
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Excellent idea to try to promote interactive behavior among life scientists.1 There is far too little interaction between scientists who are, understandably, frightened of divulging their work. There should be nothing wrong with talking about technical issues, though; that’s why so many forums have sprung up.

I won’t be tempted by a t-shirt, though, which runs the risk of making your idea look a bit gimmicky and not serious. A hat would be better.

Nigel Appleford
NHS Blood and Transport
Bristol, United Kingdom
nigel.appleford@nhsbt.nhs.uk

The US Food and Drug Administration is under pressure to protect the American population from the ill effects of bad products, yet at the same time big Pharma is under pressure by Congress and the president to reduce the costs of pharmaceuticals. One obvious method is less expensive binders (the ingredients that hold pills together) imported from perhaps some of the least scrupulous countries in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies